11 September 2024 Dimerix: FIRST PATIENT ENTERS DMX-200 OPEN LABEL EXTENSION STUDY AFTER SUCCESFULLY COMPLETING ACTION3 PHASE 3 TRIAL 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post